Skip to main content

and
  1. No Access

    Article

    Dual-phase 18F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer

    Recently, dual-phase 18F-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) was shown to be useful in the differentiation between malignant and benign pancreatic lesions. The aim of this prospectiv...

    Andrej Lyshchik, Tatsuya Higashi in European Journal of Nuclear Medicine and M… (2005)

  2. No Access

    Article

    Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer

    The usefulness of fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiated thyroid cancer (DTC) has been demonstrated by many investigators, but in only a small number of studi...

    Masahiro Iwata, Kanji Kasagi, Takashi Misaki in European Journal of Nuclear Medicine and M… (2004)

  3. No Access

    Article

    FDG-PET of autoimmune-related pancreatitis: preliminary results

    The purpose of this retrospective study was to elucidate the fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings in autoimmune-related pancreatitis (AIP), which is a reversible chro...

    Yuji Nakamoto, Tsuneo Saga, Takayoshi Ishimori in European Journal of Nuclear Medicine (2000)

  4. No Access

    Article

    Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity

    For the purpose of radioimmunotherapy, labelling of monoclonal antibody with high specific activity is often necessary, especially when using a radionuclide with a shorter half-life. Polyamine dendrimers (PAM...

    Hisataka Kobayashi, Noriko Sato, Tsuneo Saga in European Journal of Nuclear Medicine (2000)

  5. No Access

    Article

    Technetium-99m (V)-dimercaptosuccinic acid: Normal accumulation in the breasts

    Technetium-99m (V)-dimercaptosuccinic acid (DMSA) is a tumour-imaging agent which has been used to evaluate medullary thyroid cancer and soft tissue tumours. Physiological uptake has been demonstrated in the k...

    Yuji Nakamoto, Harumi Sakahara, Hisataka Kobayashi in European Journal of Nuclear Medicine (1997)